FoodOct 1, 2025
None - unlabeled bulk (private-label consignee) Generic Name: Dietary Supplement Strength recall — FDA H-0623-2025
Potential peanut protein cross-contact.
Class IIFDA: TerminatedExtract Labs, Inc.
October 2025 recalls — page 6
These records include useful source details for the selected month.
DrugOct 1, 2025
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate recall — FDA D-0673-2025
Failed Impurities/Degradation Specifications:
Class IIIFDA: OngoingGranules Pharmaceuticals Inc.
DrugOct 1, 2025
Private Label Skin Care Torrey Pines Dermatology & Laser Center Benzaderm BPO Cleanser 10% recall — FDA D-0665-2025
Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.
Class IIFDA: OngoingPrivate Label Skin Care Inc.
DrugOct 1, 2025
Private Label Skin Care Skin MD by Dr Monika Kiripolsky, Body Acne Cleanser recall — FDA D-0664-2025
Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.
Class IIFDA: OngoingPrivate Label Skin Care Inc.
DrugOct 1, 2025
Private Label Skin Care Micronized BPO Gel Cleanser 10% (Benzoyl Peroxide 10%) Pantea MD , 7 recall — FDA D-0667-2025
Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.
Class IIFDA: OngoingPrivate Label Skin Care Inc.
DrugOct 1, 2025
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate recall — FDA D-0671-2025
Failed Impurities/Degradation Specifications:
Class IIIFDA: OngoingGranules Pharmaceuticals Inc.
DrugOct 1, 2025
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate recall — FDA D-0669-2025
Failed Impurities/Degradation Specifications:
Class IIIFDA: OngoingGranules Pharmaceuticals Inc.
DrugOct 1, 2025
Private Label Skin Care mel rx Skin, NO DRAMA Benzoyl Peroxide 10% Acne Treatment, 7 oz, 201 recall — FDA D-0666-2025
Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.
Class IIFDA: OngoingPrivate Label Skin Care Inc.
DrugOct 1, 2025
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate recall — FDA D-0670-2025
Failed Impurities/Degradation Specifications:
Class IIIFDA: OngoingGranules Pharmaceuticals Inc.
DrugOct 1, 2025
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate recall — FDA D-0672-2025
Failed Impurities/Degradation Specifications:
Class IIIFDA: OngoingGranules Pharmaceuticals Inc.
DrugOct 1, 2025
Private Label Skin Care ARTISAN OF SKIN (Benzoyl Peroxide 10%) , 7 oz (201 g), Artisan of recall — FDA D-0663-2025
Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.
Class IIFDA: OngoingPrivate Label Skin Care Inc.
DrugOct 1, 2025
Private Label Skin Care edunn clarity, BP Treatment Cleanser 10% (Benzoyl Peroxide 10%), 7 recall — FDA D-0668-2025
Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.
Class IIFDA: OngoingPrivate Label Skin Care Inc.
DrugOct 1, 2025
Azelaic Acid Gel, 15%, 50 grams, For Topical Use Only recall — FDA D-0662-2025
CGMP Deviations: Market complaints received for gritty texture (grainy)
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
How to use this monthly recall archive
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.